SANTA CLARA, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of unified data and cloud analytics for the semiconductor ecosystem, today announced financial results for its first quarter ended March 31, 2023. …
MCLEAN, Va., May 09, 2023 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) today announced financial results for the first quarter ended March 31, 2023. “Appian grew cloud subscription revenue 31% in the first quarter 2023. Organizations can manage their entire …
Achieved net revenues of $2.8 million for ZORYVE® (roflumilast) cream 0.3% in the first quarter of 2023, with unit demand growth nearly doubling quarter-over-quarter Continued expansion of commercial payer coverage for ZORYVE in plaque psoriasis with over …
First Biologics License Application (BLA) Submission Completed in March 2023 Commercial Readiness Activities on track to Support Potential Commercial Launch of Lifileucel in 2023 SAN CARLOS, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, …
ZYNYZ™ is third product approved in U.S. that originated from MacroGenics' pipeline Multiple Phase 2 programs advancing in metastatic castration-resistant prostate cancer (mCRPC) Cash runway through 2025 with $270 million in non-dilutive funding …
US, May 9, 2023 /EINPresswire.com/ -- Introducing Juan Vargas, Founder and CEO of Elevated Coaching, the latest program designed to help busy professionals, executives and entrepreneurs stay on top of their physical and mental health As a …
Initiation of first pivotal Phase 3 monotherapy clinical trial of OP-1250 in second- and third-line metastatic breast cancer planned for the second half of 2023 Interim Phase 2 clinical results of OP-1250 in combination with palbociclib to be presented at …
SAN FRANCISCO, May 09, 2023 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with hematologic malignancies and solid tumors, …
MONTRĖAL, 09 mai 2023 (GLOBE NEWSWIRE) -- Senvest Capital Inc. a annoncé aujourd’hui un résultat net attribuable aux actionnaires ordinaires de 43,8 M$ ou 17,66 $ par action pour les trois mois terminés le 31 mars 2023. Pour la période correspondante de …
MONTREAL, May 09, 2023 (GLOBE NEWSWIRE) -- Senvest Capital Inc. today reported net income attributable to common shareholders of $43.8 million or $17.66 per share for the three months ended March 31, 2023. This compares to a net loss attributable to common …
Updated data from two fully enrolled Phase 2 expansion cohorts testing zotatifin-based combinations in estrogen receptor-positive (ER+) Metastatic Breast Cancer to be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2023 on June …
Total product revenue of $62.8 million for the first quarter of 2023, representing a 36% increase y-o-y; ZEJULA® achieved 44% y-o-y growth Expansion of Zai Lab’s lung cancer franchise and global oncology pipeline with a next generation antibody-drug …
- Topline data from proof-of-concept study of VRDN-001 in patients with chronic thyroid eye disease (TED) are expected in June/July 2023 - - Selection of lead subcutaneous (SC) program in TED planned for year-end 2023 - - Company adds multiple senior …
Romeoville, Ill., May 09, 2023 (GLOBE NEWSWIRE) -- Nanophase Technologies Announces First Quarter 2023 Financial Release and Conference Call Details Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven …
First Quarter Highlights: Total revenue of $232.0 million GAAP operating income of $14.1 million; non-GAAP operating income of $36.6 million GAAP consolidated net income of $11.9 million; non-GAAP consolidated net income of $29.0 million GAAP net income …
NASHVILLE, Tenn., May 09, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced its financial results for the first quarter ended March …
PITTSBURGH, May 09, 2023 (GLOBE NEWSWIRE) -- Duolingo, Inc. (NASDAQ: DUOL), the world’s leading mobile learning platform, announced results for the first quarter ended March 31, 2023 in a shareholder letter that is posted at investors.duolingo.com. “2023 …
SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate …
Q1 fiscal 2023 net sales increased 16.1% Comparable store sales grew 12.1% driven by a 7.9% increase in transactions GAAP net income increased 18.5% with diluted EPS of $0.14 Adjusted EBITDA(1) increased 36.9%, up 100 basis points as a percentage of net …
WATERTOWN, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage biotechnology company developing innovative therapies for the localized treatment of patients with chronic rhinosinusitis (CRS), today announced …
03 days 20:31:18
